Overview
The Global Anthrax Vaccines Market growing at a CAGR of 7.4% during the forecast period (2024-2031)
Anthrax is transmitted through contact with animals or contaminated animal products, but it is not spread from person to person. It has the potential to be used as a biological weapon against U.S. military personnel during combat.
Request for free sample:https://www.datamintelligence.com/download-sample/anthrax-vaccines-market
Market Growth Trends
The Rising Clinical Trials for Anthrax Vaccines are Expected to Drive Market Growth.
On April 1, 2021, Altimmune, Inc., a clinical-stage biopharmaceutical company, announced clinical data on its NasoShield intranasal anthrax vaccine candidate. The Phase 1b trial assessed the safety and immunogenicity of one- and two-dose regimens of NasoShield in healthy volunteers. This clinical trial was conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA).
Get your customized report @https://www.datamintelligence.com/customize/anthrax-vaccines-market
Market is segmented
By Product Type: Cell-Free Vaccines, Live Attenuated Vaccines
By Application: Human Use, Animal User
By End User: Hospitals, Clinics, Vaccination Centers
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Market Key Players
- Merck Co., Inc.
- Emergent Bio-Solutions
- Zoetis Inc.
- PharmaAthene Inc.
- Biogenesis Bago Inc.
- Porton Biopharma Inc.
- Colorado Serum
- Sanofi SA
- Vecol SA
- Panacea Biotec
Related Reports
Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across
